| scholarly article | Q13442814 |
| P356 | DOI | 10.1126/SCIENCE.1990441 |
| P698 | PubMed publication ID | 1990441 |
| P2093 | author name string | Mosier DE | |
| Wilson DB | |||
| Spector SA | |||
| Spector DH | |||
| Baird SM | |||
| Gulizia RJ | |||
| P433 | issue | 4995 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 791-794 | |
| P577 | publication date | 1991-02-01 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Human immunodeficiency virus infection of human-PBL-SCID mice | |
| P478 | volume | 251 |
| Q34955359 | A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity |
| Q36544848 | A model of human immunodeficiency virus encephalitis in scid mice |
| Q45766676 | A model of measles virus-induced immunosuppression: enhanced susceptibility of neonatal human PBLs |
| Q57062356 | Adeno-associated virus gene delivery of broadly neutralizing antibodies as prevention and therapy against HIV-1 |
| Q37512281 | Adoptive transfer of human lymphoid cells to severely immunodeficient mice: models for normal human immune function, autoimmunity, lymphomagenesis, and AIDS. |
| Q44267949 | Animal Models Recapitulate Aspects of HIV/CNS Disease |
| Q33957283 | Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors |
| Q34050742 | Animal models for AIDS pathogenesis |
| Q30423656 | Animal models for HIV/AIDS research |
| Q35266090 | Animal models for the study of human immunodeficiency virus infections |
| Q36364071 | Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras |
| Q28378710 | Anti-human immunodeficiency virus type 1 activity of an anti-CD4 immunoconjugate containing pokeweed antiviral protein |
| Q67713694 | Antigenic variation in Giardia lamblia: infection of congenially athymic nude and scid mice |
| Q21144657 | Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice |
| Q73468707 | Apoptosis in AIDS |
| Q45723526 | Assessment of oral transmission using cell-free human immunodeficiency virus-1 in mice reconstituted with human peripheral blood leucocyte |
| Q91607012 | Benefits and limitations of humanized mice in HIV persistence studies |
| Q33783578 | CD4-immunoglobulin G2 protects Hu-PBL-SCID mice against challenge by primary human immunodeficiency virus type 1 isolates. |
| Q33315029 | Can the new humanized mouse model give HIV research a boost |
| Q37998496 | Candidate antibody-based therapeutics against HIV-1. |
| Q35832063 | Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease |
| Q39355189 | Chemokine receptor CCR5 genotype influences the kinetics of human immunodeficiency virus type 1 infection in human PBL-SCID mice. |
| Q30424775 | Conditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function |
| Q34502108 | Current progress in the development of a prophylactic vaccine for HIV-1. |
| Q35745831 | DNA vaccines against human immunodeficiency virus type 1 in the past decade |
| Q39879562 | Deletion of nef slows but does not prevent CD4-positive T-cell depletion in human immunodeficiency virus type 1-infected human-PBL-SCID mice |
| Q40536044 | Developing animal models for AIDS research--progress and problems |
| Q35127565 | Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice |
| Q33782118 | Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes |
| Q40977382 | Distinct rate and patterns of human CD4+ T-cell depletion in hu-PBL-SCID mice infected with different isolates of the human immunodeficiency virus |
| Q39432795 | Dynamics of memory and naïve CD8+ T lymphocytes in humanized NOD/SCID/IL-2Rgammanull mice infected with CCR5-tropic HIV-1. |
| Q36816122 | Ectopic lymphokine gene expression in human peripheral blood lymphocytes in vivo |
| Q36698495 | Efficient production of human immunodeficiency virus proteins in transgenic mice |
| Q35201052 | Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2Rγ-/- mice: a promising model for studying human disease |
| Q36879170 | Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design". |
| Q52031524 | Evaluation of immune memory of human lymphocytes engrafted in SCID mice. |
| Q41119643 | FP-21399 blocks HIV envelope protein-mediated membrane fusion and concentrates in lymph nodes |
| Q47217844 | From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection. |
| Q34135605 | Generation of improved humanized mouse models for human infectious diseases |
| Q41320990 | Genetic Modification of Human Peripheral Blood Lymphocytes with a Transdominant Negative Form of Rev: Safety and Toxicity |
| Q24651142 | HIV type-1 infection of the cotton rat (Sigmodon fulviventer and S. hispidus) |
| Q38905274 | HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model |
| Q34875979 | HIV-1 replication cycle |
| Q35831685 | Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease model |
| Q42988931 | Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice |
| Q34100221 | Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2-/-gammac-/- mice |
| Q33645828 | Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants. |
| Q72344503 | Human T cells in hu-PBL-SCID mice proliferate in response to Daudi lymphoma and confer anti-tumour immunity |
| Q40698897 | Human T-cell lineage development in foetal thymus-engrafted SCID mice |
| Q33782430 | Human dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/SCID mice and confer partial protection against [...] |
| Q33995307 | Human hemato-lymphoid system mice: current use and future potential for medicine |
| Q45854222 | Human immunodeficiency virus (HIV)-infected cells and free virus directly activate the classical complement pathway in rabbit, mouse and guinea-pig sera; activation results in virus neutralization by virolysis |
| Q41096686 | Human immunodeficiency virus infection of human cells transplanted to severe combined immunodeficient mice. |
| Q35784905 | Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice. |
| Q33816889 | Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection. |
| Q33786418 | Human lymphoblastoid CD4(+) T cells become permissive to macrophage-tropic strains of human immunodeficiency virus type 1 after passage into severe combined immunodeficient mice through in vivo upregulation of CCR5: in vivo dynamics of CD4(+) [...] |
| Q89755936 | Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease and Regenerative Medicine |
| Q28756080 | Humanized NOD/SCID/IL2Rgamma(null) mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis |
| Q37179146 | Humanized mice for the study of infectious diseases |
| Q26996648 | Humanized mice: novel model for studying mechanisms of human immune-based therapies |
| Q35567215 | Humanized mouse models for HIV-1 infection of the CNS. |
| Q34533579 | Humanized mouse models of epstein-barr virus infection and associated diseases |
| Q64087572 | Immune Activations and Viral Tissue Compartmentalization During Progressive HIV-1 Infection of Humanized Mice |
| Q36553607 | Immune-Deficient Mice as Models for Human Hematopoietic Disease |
| Q35747109 | Immunological characterization of human vaginal xenografts in immunocompromised mice: development of a small animal model for the study of human immunodeficiency virus-1 infection |
| Q26851152 | Impacts of humanized mouse models on the investigation of HIV-1 infection: illuminating the roles of viral accessory proteins in vivo |
| Q35795065 | Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice. |
| Q44001900 | In vitro preactivated human T cells engraft in SCID mice and migrate to murine lymphoid tissues |
| Q41404314 | Induction of primary antigen-specific immune reponses in SCID-hu-PBL by coupled T-B epitopes |
| Q39796585 | Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-ce |
| Q37247943 | Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice |
| Q28369113 | Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands |
| Q38263295 | Latest animal models for anti-HIV drug discovery |
| Q30373903 | Long lasting control of viral rebound with a new drug ABX464 targeting Rev - mediated viral RNA biogenesis. |
| Q35124100 | MDL 74,968, a new acyclonucleotide analog: activity against human immunodeficiency virus in vitro and in the hu-PBL-SCID.beige mouse model of infection |
| Q37316026 | Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development. |
| Q34920166 | Mice with human immune system components as in vivo models for infections with human pathogens |
| Q37223070 | Microbicide safety/efficacy studies in animals: macaques and small animal models |
| Q41116459 | Modeling AIDS in a mouse |
| Q40497129 | Modeling human retroviral pathogenesis and antiretroviral gene therapy in the SCID mouse |
| Q35914370 | Multiple restrictions of human immunodeficiency virus type 1 in feline cells |
| Q39124981 | Mutational analysis of human immunodeficiency virus type 1 (HIV-1) accessory genes: requirement of a site in the nef gene for HIV-1 replication in activated CD4+ T cells in vitro and in vivo. |
| Q36622723 | Neoplastic stem cells: a novel therapeutic target in clinical oncology |
| Q33860721 | Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. |
| Q37034635 | Nonprimate models of HIV-1 infection and pathogenesis |
| Q40180319 | Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: evaluation of new 6-desfluoroquinolone derivatives |
| Q35035610 | PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads |
| Q43872744 | Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1. |
| Q24634681 | Pathogenesis of human immunodeficiency virus infection |
| Q47864989 | Peritoneal macrophages play an important role in eliminating human cells from severe combined immunodeficient mice transplanted with human peripheral blood lymphocytes |
| Q40064566 | Persistent infection of normal mice with human immunodeficiency virus |
| Q35128255 | Potent activity of 2'-beta-fluoro-2',3'-dideoxyadenosine against human immunodeficiency virus type 1 infection in hu-PBL-SCID mice. |
| Q37333100 | Potent activity of a nucleoside reverse transcriptase inhibitor, 4'-ethynyl-2-fluoro-2'-deoxyadenosine, against human immunodeficiency virus type 1 infection in a model using human peripheral blood mononuclear cell-transplanted NOD/SCID Janus kinase |
| Q33781391 | Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse model. |
| Q37363070 | Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components |
| Q36890224 | Potential of the scid mouse as a host for human tumors |
| Q28731318 | Pre-clinical evaluation of a 213Bi-labeled 2556 antibody to HIV-1 gp41 glycoprotein in HIV-1 mouse models as a reagent for HIV eradication |
| Q39339749 | Primary HIV-1 infection of human CD4+ T cells passaged into SCID mice leads to selection of chronically infected cells through a massive fas-mediated autocrine suicide of uninfected cells |
| Q39878783 | Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain |
| Q73433454 | Protection of hu-PBL-SCID/beige mice from HIV-1 infection by a 6-mer modified oligonucleotide, R-95288 |
| Q36872332 | Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design |
| Q36175538 | Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. |
| Q33798154 | Resistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of nonprogressors is mediated by CD8(+) T cells and associated with a proliferative response to p24 antigen |
| Q83226952 | Rhabdo-immunodeficiency virus, a murine model of acute HIV-1 infection |
| Q35646248 | SCID mice in the study of human autoimmune diseases |
| Q35870538 | Selective transmission of human immunodeficiency virus type 1 variants to SCID mice reconstituted with human peripheral blood monoclonal cells. |
| Q53185928 | Severe necroinflammatory reaction caused by natural killer cell-mediated Fas/Fas ligand interaction and dendritic cells in human hepatocyte chimeric mouse. |
| Q45779117 | Signs and lesions of experimental Sendai virus infection in two genetically distinct strains of SCID/beige mice |
| Q26849806 | Studies of retroviral infection in humanized mice |
| Q33683207 | T cell dynamics in HIV-1 infection. |
| Q35872456 | T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells. |
| Q38832507 | TALEN gene editing takes aim on HIV. |
| Q28379433 | TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus |
| Q77977537 | The CD4 Loss in AIDS Patients is not Immunopathologically Mediated |
| Q33782350 | The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes. |
| Q39036388 | The envelope gp120 gene of human immunodeficiency virus type 1 determines the rate of CD4-positive T-cell depletion in SCID mice engrafted with human peripheral blood leukocytes |
| Q44582551 | The fate of human peripheral blood lymphocytes after transplantation into SCID mice |
| Q49062938 | The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection |
| Q37900419 | The mouse is out of the bag: insights and perspectives on HIV-1-infected humanized mouse models |
| Q46187118 | The mouse viral outgrowth assay: avatars for the detection of HIV-1 reservoirs |
| Q37058550 | The use of rodent models to investigate host-bacteria interactions related to periodontal diseases |
| Q35206268 | The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment |
| Q33825360 | Transfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection |
| Q34391256 | Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development. |
| Q36368488 | Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. |
| Q60267505 | U937-SCID mouse xenografts: a new model for acute in vivo HIV-1 infection suitable to test antiviral strategies |
| Q33942071 | Virus and target cell evolution in human immunodeficiency virus type 1 infection |
| Q39588750 | cis expression of the F12 human immunodeficiency virus (HIV) Nef allele transforms the highly productive NL4-3 HIV type 1 to a replication-defective strain: involvement of both Env gp41 and CD4 intracytoplasmic tails. |
| Q36466103 | hu-PBL-SCID Mice: A Model for Human Immune Function, AIDS, and Lymphomagenesis |
Search more.